Murine gammaherpesvirus-68 glycoprotein B presents a difficult neutralization target to monoclonal antibodies derived

Laurent Gillet1, Michael B Gill1, Susanna Colaco1

  • 1Division of Virology, Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QP, UK.

Insights

Murine gammaherpesvirus-68 (MHV-68) glycoprotein B (gB) is a difficult target for antibody neutralization. A specific IgM antibody targeting the gB N terminus showed limited ability to inhibit viral infectivity.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Persistent viruses must evade antibody neutralization to spread in immune hosts.
  • Murine gammaherpesvirus-68 (MHV-68) is a model for studying viral resistance to neutralization.
  • Viral glycoprotein B (gB) is essential for infectivity and a potential neutralization target.

Purpose of the Study:

  • To investigate if antibodies targeting MHV-68 glycoprotein B (gB) can neutralize viral infectivity.
  • To determine the mechanism and efficacy of antibody-mediated neutralization of MHV-68.
  • To assess the potential of gB as a target for improved infection control.

Main Methods:

  • Generation of monoclonal antibodies (mAbs) against MHV-68 from infected mice.
  • Testing the effect of gB-specific mAbs on MHV-68 infectivity and entry into BHK-21 and NMuMG cells.
  • Analyzing the role of antibody structure (IgM pentamers vs. monomers) in neutralization.

Main Results:

  • gB-specific mAbs were common, but only an N-terminal IgM significantly reduced virion infectivity.
  • This IgM inhibited MHV-68 entry at a post-binding step, closely linked to membrane fusion.
  • Neutralization was severely compromised when the IgM was reduced to monomers, indicating the importance of its pentameric structure.
  • Antibody treatment did not completely block infection in cell lines and failed to block infection in mice.

Conclusions:

  • The MHV-68 gB is a challenging target for antibody-mediated neutralization.
  • The pentameric structure of IgM is crucial for its limited neutralizing activity against MHV-68.
  • Strategies to overcome antibody resistance are needed for effective MHV-68 infection control.